Search

everythinglearnresearchcommunity

for

Search:↓

Current research explores hair growth drugs, while future research aims for personalized treatments.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

People with alopecia areata are more likely to have other immune-related conditions.

Tph cells are linked to the severity of systemic lupus erythematosus.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

UV light helped human hair transplants survive in mice without broad immunosuppression.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Regulatory T cells enhance bone formation by influencing cell mechanics.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

North American ginseng extract helped regrow hair in balding mice.

The treatment helped some patients with severe hair loss regrow hair.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Age-related immune changes significantly affect disease development in other systems.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

T cells and bacteria in the gut and skin help maintain health and protect against disease.